XIIlab

At a glance

XIIlab filed 39 disclosures in the last 12 months, including 9 contract. The most recent key filing was on Oct 27: Worth 17% of last year's revenue, over about 43 months.

Revenue for 2025 was ₩10.3B, up 13% on 2024. It made an operating loss of ₩3.2B. Debt was 17% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩3.1B and operating loss of ₩4.6B.

The 2025 annual report lists 68 employees with an average tenure of 2.8 years and average pay of ₩40.4M, #1741 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩182.6M each on average. It paid no cash dividend for 2025. 이우영 and related parties held 31.53% at year end.

From the 2025 annual report

Staff: 68 (51 men, 17 women), of whom 2 on fixed-term contracts. Total pay for the year: ₩3.6B. Directors and auditors: 5, paid ₩913.2M in total.

No cash dividend was paid for 2025.

Largest shareholder

이우영 holds 29.90%; with 9 related parties the group holds 31.53% of common shares at year end (from 43.18% at the start of the year).

Auditor: 동성회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

7 new supply contracts worth 450% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary